Bovine Corneal Extract

Bovine corneal extract is a research compound derived from cow corneas containing collagen Type V and keratan sulfate. It currently serves exclusively as a testing material in laboratory assays with no documented therapeutic applications.

Origin & History

Bovine corneal extract is derived from the corneal tissue of cattle, obtained as a by-product from abattoirs. The extraction process involves enzymatic hydrolysis with pepsin in acetic acid solution, followed by salt precipitation and ultrafiltration to isolate specific proteins, primarily collagen Type V (comprising 10-20% of corneal collagen) and glycosaminoglycans like keratan sulfate.

Historical & Cultural Context

No information about historical or traditional medicinal use of bovine corneal extract is available in the provided research sources. Current applications appear limited to modern laboratory research methods.

Health Benefits

• No clinical health benefits documented - available research focuses only on extraction methods and biochemical characterization
• Currently used solely as a research tool in the BCOP assay for testing eye irritation potential of substances
• Contains collagen Type V and keratan sulfate, but therapeutic effects in humans remain unstudied
• No evidence for vision support or other health claims in the provided research
• Further clinical research needed to establish any potential health benefits

How It Works

Bovine corneal extract provides structural proteins including collagen Type V, which forms heterotypic fibrils with collagen Type I in connective tissues. The keratan sulfate component acts as a proteoglycan that maintains corneal transparency and hydration. However, oral bioavailability and systemic effects of these compounds remain unestablished.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses evaluating bovine corneal extract as a therapeutic supplement were found in the available research. The only clinical application mentioned is the BCOP (Bovine Corneal Opacity and Permeability) assay developed by Gautheron et al. (1992), which uses bovine corneal tissue as a research tool to evaluate ocular irritancy rather than as evidence of therapeutic use.

Clinical Summary

No clinical trials have evaluated bovine corneal extract as a therapeutic supplement. Current research is limited to extraction methodology studies and biochemical characterization for laboratory use. The primary application remains the Bovine Corneal Opacity and Permeability (BCOP) assay for testing ocular irritation potential of chemicals. Without human studies, therapeutic efficacy and optimal dosing remain completely unknown.

Nutritional Profile

Bovine Corneal Extract is a protein-dominant biological material derived from bovine (cattle) corneal tissue. Primary structural protein is collagen Type V, which constitutes a significant portion of the corneal stroma alongside collagen Type I (approximately 70-80% of dry corneal weight is collagen). Keratan sulfate proteoglycans (KSPGs) are a defining bioactive component, including lumican, keratocan, and mimecan, which are unique to corneal tissue and contribute to its transparency. Glycoproteins and fibronectin are present in smaller quantities. The extract is rich in amino acids characteristic of collagen: glycine (~33% of residues), proline, hydroxyproline, and alanine dominate the amino acid profile. Water content of native corneal tissue is approximately 78%, meaning dry-weight protein concentrations are substantially higher than wet-weight measurements. Keratan sulfate content in bovine cornea is estimated at 10-15 mg per gram of dry tissue, making it one of the richest natural sources of this glycosaminoglycan. Zinc and calcium are present as trace minerals associated with corneal enzyme systems (e.g., carbonic anhydrase). No meaningful carbohydrate, dietary fiber, or lipid fractions are present beyond glycoconjugate linkages. Bioavailability in oral or topical contexts is entirely unstudied; as a research-grade extract used in the BCOP (Bovine Corneal Opacity and Permeability) assay, no absorption, distribution, or metabolism data exists for human supplemental use.

Preparation & Dosage

No clinically studied dosage ranges for bovine corneal extract supplementation are available in the research literature. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research to recommend synergistic combinations

Safety & Interactions

Safety data for bovine corneal extract supplementation is unavailable due to lack of human studies. Potential concerns include bovine spongiform encephalopathy (BSE) transmission risk from bovine-derived materials. Allergic reactions to bovine proteins represent another theoretical risk. Pregnant and breastfeeding women should avoid use due to complete absence of safety data.